The U.S. Food and Drug Administration has approved Onswik (insulin efsitora alfa-gobe) injection, a long-acting insulin analog, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The U.S. Food and Drug Administration has approved Onswik (insulin efsitora alfa-gobe) injection, a long-acting insulin analog, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
No comments yet. Be the first to share your thoughts.